Search results for: 'daa tech eu'
- Did you mean
- dia tech eu
- d8aa tech eu
- Related search terms
- technology advancements transforming the (as(asia pacific) intelligent automation market (20(2020 2024)
- Technology Advancements and Industry Collaborations Powering the ASEAN Electric Two-wheeler Market, 2025
- DAA0-01-00-00-00.
- Technology and Sustainability to drive recover in UK FM market®ions=285
- daas 01 00 00 00
-
27 Aug 2021  |  North America  |  Market Research
US and EU Upstream Bioprocessing Growth Opportunities
Increasing Demand for Consumables and Single-use Technologies to Drive Growth in Upstream Bioprocessing
The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Aug 2021  |  North America  |  Market Research
US and EU Biotech Industry VC Investment Growth Opportunities
Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI
With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...
$2,450.00
Special Price $1,837.50 save 25 %
-
30 Jun 2021  |  North America  |  Market Research
US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities
Telegenetic Counseling to Revolutionize Access to Patient Care
In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...
$2,450.00
Special Price $1,837.50 save 25 %
-
24 Apr 2024  |  North America  |  Market Outlook
Global Digital Health Outlook and Growth Opportunities, 2024
The Move to Deliver Care Beyond Hospital Walls and Unique AI Use Cases will Ensure Transformational Growth
The digital health industry has maintained a consistent growth trajectory. Investing in technologies that help organizations achieve the quintuple aim of healthcare is a constant priority. However, high inflation and tight monetary policy will impact the investment landscape as it shifts from top-line growth to profitability. The use of AI tech...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2020  |  North America  |  Market Research
Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026
Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth
The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jan 2020  |  North America  |  Market Research
Predictions for the Global Life Sciences Industry, 2020
COVID-19 Pandemic will Drive New Digital-tech Adoption in Drug Discovery and Testing Services, and Federal Funding will Encourage Stronger Product Pipelines
The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...
$1,500.00
Special Price $1,125.00 save 25 %
-
31 Jan 2024  |  North America  |  Market Research
Digital Health Regulations in North America and Europe: Growth Opportunities 2023
Innovative Business Models and Technologies are Leading to the Introduction of Disruptive Regulations
This report examines the regulations surrounding digital health in North America and Europe. It provides a general analysis of key national and regional regulatory updates that will impact digital health players and influence market dynamics. The regulatory documents considered are those governing the healthcare sector and applicable to digital hea...
$2,450.00
Special Price $1,837.50 save 25 %
-
01 Jul 2015  |  North America  |  Market Research
Analysis of the US and European Diabetes Diagnostics Market
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
$6,950.00
Special Price $5,212.50 save 25 %
-
23 Feb 2021  |  North America  |  Market Research
AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market
Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities
The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...
$4,950.00
Special Price $3,712.50 save 25 %
-
04 Sep 2018  |  North America  |  Market Research
Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...
$3,000.00
Special Price $2,250.00 save 25 %